Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

This study has been terminated.
(Dose over MTD reached)
Copenhagen University Hospital at Herlev
Bispebjerg Hospital
TopoTarget A/S
Roche Pharma AG
Information provided by:
Herlev Hospital Identifier:
First received: August 24, 2010
Last updated: August 3, 2011
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)